4 ms·
True that a big part of the cost is absorbing the costs of failed drugs, but most of it is in clinical trials, which is normally past the academia setting.
by someNameIG 2y ago
True that a big part of the cost is absorbing the costs of failed drugs, but most of it is in clinical trials, which is normally past the academia setting.
- consteval 2y agoIf I had to guess, a tiny tiny percent of all potential drugs make it to clinical trails. So again, now you're looking at 1 in 10,000. You're only looking at the 1, ignoring the 9,999, and saying "look pharma pays for all of it!" How much research at unis ends up being completely worthless from a pharmaceutical product perspective? Almost all of it. But how many products began based on research conducted at universities? ... all of them.